Recurrent Acute Myocardial Infarction in a Patient with Severe Coronary Artery Ectasia: Implication of Antithrombotic

Tomoko Tomioka1, Satoshi Takeuchi1, Yoshitaka Ito1

  • 1Department of Cardiology, South-Miyagi Medical Center, Shibata, Miyagi, Japan.

Insights

Recurrent acute myocardial infarction (AMI) in a patient with coronary artery ectasia was linked to local thrombus formation. Anticoagulation therapy showed effectiveness in preventing further events.

Area of Science:

  • Cardiology
  • Vascular Medicine

Background:

  • Acute myocardial infarction (AMI) has diverse causes beyond plaque rupture, including thromboembolism and coronary thrombosis.
  • Coronary artery ectasia is an underrecognized cause of myocardial infarction.

Observation:

  • A 78-year-old woman experienced two episodes of AMI within one month in the distal right coronary artery.
  • Coronary angiography revealed no plaque rupture or stenosis, but identified coronary artery ectasia.
  • Doppler velocimetry showed sluggish blood flow in the ectatic segment, suggesting local thrombus formation.

Findings:

  • The recurrent AMI events were attributed to local thrombus formation within the coronary artery ectasia segment.
  • Anticoagulation therapy with warfarin was initiated after the second event.
  • Post-treatment evaluation confirmed the absence of plaque rupture and thrombus, indicating therapeutic effectiveness.

Implications:

  • Local thrombus formation due to stagnant blood flow in coronary artery ectasia can cause AMI.
  • Anticoagulation therapy may be a viable strategy for managing patients with coronary artery ectasia and recurrent AMI, irrespective of atrial fibrillation.
  • This case highlights the importance of considering non-atherosclerotic causes of AMI.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
611
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
286
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
372